<p>Dr. Rivosecchi discusses his team's research that challenged the typical fentanyl-based sedation with hydromorphone-based sedation for ECMO patients - Episode 31. Full manuscript available at: <a href="https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2385">https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2385</a></p>

Dr. Rivosecchi discusses his team's research that challenged the typical fentanyl-based sedation with hydromorphone-based sedation for ECMO patients - Episode 31. Full manuscript available at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2385

<p>Dr. Rivosecchi discusses his team's research that challenged the typical fentanyl-based sedation with hydromorphone-based sedation for ECMO patients - Episode 31. Full manuscript available at: <a href="https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2385" rel="noopener noreferrer">https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2385</a></p>

Hydromorphone- vs. Fentanyl-based sedation in ECMO - Episode 31

This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice.
ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.

Medicine

Health & Fitness

This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice. ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.

Share Hydromorphone- vs. Fentanyl-based sedation in ECMO - Episode 31

Sign up to save your podcasts

Hydromorphone- vs. Fentanyl-based sedation in ECMO - Episode 31

Hydromorphone- vs. Fentanyl-based sedation in ECMO - Episode 31

More shows like ACCP JOURNALS

EMCrit FOAM Feed

Gastropod

The Daily

Today, Explained